Cohance Lifesciences: Encumbrance on 57.49% Shares Released

CSC Global Capital Markets (Singapore) Pte. Ltd., as security agent, has disclosed the release of encumbrances on 57.49% of Cohance Lifesciences Limited's equity shares. These shares were indirectly encumbered through covenants and offshore pledge agreements related to notes issued by promoters Berhyanda Limited and Jusmiral Holdings Limited. The encumbrances were released effective June 16, 2026, following the full repayment of the notes. This action lifts restrictions on disposal and security creation for these promoter holdings.